Derivation and Validation of a Prediction Model of End-Stage Renal Disease in Patients With Type 2 Diabetes Based on a Systematic Review and Meta-analysis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Apr 1

PMID 35360073

Authors

Qiuyue Ren

Dong Chen

Xinbang Liu

Ronglu Yang

Lisha Yuan

Min Ding

Ning Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: To develop and validate a model for predicting the risk of end-stage renal disease (ESRD) in patients with type 2 diabetes.

Methods: The derivation cohort was from a meta-analysis. Statistically significant risk factors were extracted and combined to the corresponding risk ratio (RR) to establish a risk assessment model for ESRD in type 2 diabetes. All risk factors were scored according to their weightings to establish the prediction model. Model performance is evaluated using external validation cohorts. The outcome was the occurrence of ESRD defined as eGFR<15 ml min 1.73 m or received kidney replacement therapy (dialysis or transplantation).

Results: A total of 1,167,317 patients with type 2 diabetes were included in our meta-analysis, with a cumulative incidence of approximately 1.1%. The final risk factors of the prediction model included age, sex, smoking, diabetes mellitus (DM) duration, systolic blood pressure (SBP), hemoglobin A1c (HbA1c), estimated glomerular filtration rate (eGFR), and triglyceride (TG). All risk factors were scored according to their weightings, with the highest score being 36.5. External verification showed that the model has good discrimination, AUC=0.807(95%CI 0.753-0.861). The best cutoff value is 16 points, with the sensitivity and specificity given by 85.33% and 60.45%, respectively.

Conclusion: The study established a simple risk assessment model including 8 routinely available clinical parameters for predicting the risk of ESRD in type 2 diabetes.

Citing Articles

Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts.

Wang S, Sun N, Liu P, Qian W, Xu Q, Yang D Ital J Pediatr. 2025; 51(1):55.

PMID: 39985083 PMC: 11846198. DOI: 10.1186/s13052-025-01889-w.

Development and validation of a risk assessment model for predicting the failure of early medical abortions: A clinical prediction model study based on a systematic review and meta-analysis.

Liu A, Xu B, Li X, Yu Y, Guan H, Sun X PLoS One. 2024; 19(12):e0315025.

PMID: 39705275 PMC: 11661585. DOI: 10.1371/journal.pone.0315025.

Scoring and validation of a simple model for predicting diabetic retinopathy in patients with type 2 diabetes based on a meta-analysis approach of 21 cohorts.

Guo H, Han F, Qu J, Pan C, Sun B, Chen L Ann Med. 2024; 56(1):2413920.

PMID: 39392052 PMC: 11485693. DOI: 10.1080/07853890.2024.2413920.

Predictors of chronic kidney disease survival in type 2 diabetes: a 12-year retrospective cohort study utilizing estimated glomerular filtration rate.

Jairoun A, Ping C, Ibrahim B Sci Rep. 2024; 14(1):9014.

PMID: 38641627 PMC: 11031608. DOI: 10.1038/s41598-024-58574-x.

Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease.

Zheng X, Gao Y, Huang Y, Dong R, Yang M, Zhang X BMC Nephrol. 2023; 24(1):379.

PMID: 38115082 PMC: 10731831. DOI: 10.1186/s12882-023-03428-3.

References

Chang P, Chien L, Lin Y, Chiou H, Chiu W . Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease. Medicine (Baltimore). 2015; 94(47):e2051. PMC: 5058977. DOI: 10.1097/MD.0000000000002051. View

Keane W, Brenner B, de Zeeuw D, Grunfeld J, McGill J, Mitch W . The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003; 63(4):1499-507. DOI: 10.1046/j.1523-1755.2003.00885.x. View

Bruno G, Biggeri A, Merletti F, Bargero G, Ferrero S, Pagano G . Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study. Diabetes Care. 2003; 26(8):2353-8. DOI: 10.2337/diacare.26.8.2353. View

Hostetter T . Prevention of end-stage renal disease due to type 2 diabetes. N Engl J Med. 2001; 345(12):910-2. DOI: 10.1056/NEJM200109203451209. View

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

Shimizu M, Furuichi K, Toyama T, Kitajima S, Hara A, Kitagawa K . Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care. 2013; 36(11):3655-62. PMC: 3816871. DOI: 10.2337/dc13-0298. View

Brenner B, Cooper M, de Zeeuw D, Keane W, Mitch W, Parving H . Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345(12):861-9. DOI: 10.1056/NEJMoa011161. View

Lee E, Lee V, Lu M, Lee J, Russell D, Yeh J . Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study. Diabetes. 1994; 43(4):572-9. DOI: 10.2337/diab.43.4.572. View

Chen D, Wang M, Shang X, Liu X, Liu X, Ge T . Development and validation of an incidence risk prediction model for early foot ulcer in diabetes based on a high evidence systematic review and meta-analysis. Diabetes Res Clin Pract. 2021; 180:109040. DOI: 10.1016/j.diabres.2021.109040. View

10.

Levey A, Stevens L, Schmid C, Zhang Y, Castro 3rd A, Feldman H . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12. PMC: 2763564. DOI: 10.7326/0003-4819-150-9-200905050-00006. View

11.

Satirapoj B, Pooluea P, Nata N, Supasyndh O . Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study. J Diabetes Complications. 2019; 33(9):675-681. DOI: 10.1016/j.jdiacomp.2019.05.013. View

12.

Humphrey L, Ballard D, Frohnert P, Chu C, OFallon W, PALUMBO P . Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med. 1989; 111(10):788-96. DOI: 10.7326/0003-4819-111-10-788. View

13.

Major R, Shepherd D, Medcalf J, Xu G, Gray L, Brunskill N . The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study. PLoS Med. 2019; 16(11):e1002955. PMC: 6834237. DOI: 10.1371/journal.pmed.1002955. View

14.

El Nahas A, Bello A . Chronic kidney disease: the global challenge. Lancet. 2005; 365(9456):331-40. DOI: 10.1016/S0140-6736(05)17789-7. View

15.

Landray M, Emberson J, Blackwell L, Dasgupta T, Zakeri R, Morgan M . Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis. 2010; 56(6):1082-94. PMC: 2991589. DOI: 10.1053/j.ajkd.2010.07.016. View

16.

Kramer H, Nguyen Q, Curhan G, Hsu C . Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003; 289(24):3273-7. DOI: 10.1001/jama.289.24.3273. View

17.

Samuelsson O, Mulec H, Knight-Gibson C, Attman P, Kron B, Larsson R . Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant. 1997; 12(9):1908-15. DOI: 10.1093/ndt/12.9.1908. View

18.

Muntner P, Coresh J, Smith J, Eckfeldt J, Klag M . Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int. 2000; 58(1):293-301. DOI: 10.1046/j.1523-1755.2000.00165.x. View

19.

. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. Am J Kidney Dis. 2012; 60(5):850-86. DOI: 10.1053/j.ajkd.2012.07.005. View

20.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View